These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35081341)

  • 21. Activation of Stimulator of Interferon Genes in Hepatocytes Suppresses the Replication of Hepatitis B Virus.
    Guo F; Tang L; Shu S; Sehgal M; Sheraz M; Liu B; Zhao Q; Cheng J; Zhao X; Zhou T; Chang J; Guo JT
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28717041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B Virus Particles Activate Toll-Like Receptor 2 Signaling Initially Upon Infection of Primary Human Hepatocytes.
    Zhang Z; Trippler M; Real CI; Werner M; Luo X; Schefczyk S; Kemper T; Anastasiou OE; Ladiges Y; Treckmann J; Paul A; Baba HA; Allweiss L; Dandri M; Gerken G; Wedemeyer H; Schlaak JF; Lu M; Broering R
    Hepatology; 2020 Sep; 72(3):829-844. PubMed ID: 31925967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deacetylation of Notch1 by SIRT1 contributes to HBsAg- and HBeAg-mediated M2 macrophage polarization.
    Li J; Yu M; Zong R; Fan C; Ren F; Wu W; Li C
    Am J Physiol Gastrointest Liver Physiol; 2022 Apr; 322(4):G459-G471. PubMed ID: 35234049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MafF Is an Antiviral Host Factor That Suppresses Transcription from Hepatitis B Virus Core Promoter.
    Ibrahim MK; Abdelhafez TH; Takeuchi JS; Wakae K; Sugiyama M; Tsuge M; Ito M; Watashi K; El Kassas M; Kato T; Murayama A; Suzuki T; Chayama K; Shimotohno K; Muramatsu M; Aly HH; Wakita T
    J Virol; 2021 Jul; 95(15):e0076721. PubMed ID: 33980595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo.
    Zhao Z; Hong W; Zeng Z; Wu Y; Hu K; Tian X; Li W; Cao Z
    J Biol Chem; 2012 Aug; 287(36):30181-90. PubMed ID: 22791717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages.
    Souissi IJ; Billiet L; Cuaz-Pérolin C; Slimane MN; Rouis M
    Exp Cell Res; 2008 Nov; 314(18):3405-14. PubMed ID: 18823978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MCPIP1 reduces HBV-RNA by targeting its epsilon structure.
    Li Y; Que L; Fukano K; Koura M; Kitamura K; Zheng X; Kato T; Aly HH; Watashi K; Tsukuda S; Aizaki H; Watanabe N; Sato Y; Suzuki T; Suzuki HI; Hosomichi K; Kurachi M; Wakae K; Muramatsu M
    Sci Rep; 2020 Nov; 10(1):20763. PubMed ID: 33247161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response.
    Stoop JN; Woltman AM; Biesta PJ; Kusters JG; Kuipers EJ; Janssen HL; van der Molen RG
    Hepatology; 2007 Sep; 46(3):699-705. PubMed ID: 17654744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prior transient exposure to interleukin-21 delivered by recombinant adeno-associated virus vector protects mice from hepatitis B virus persistence.
    Shen Z; Gao Z; Gu C; Wu J; Wang J; Zhang J; Xie Y; Liu J
    Antiviral Res; 2021 Jun; 190():105076. PubMed ID: 33865876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral response elicited against avian influenza virus infection following activation of toll-like receptor (TLR)7 signaling pathway is attributable to interleukin (IL)-1β production.
    Abdul-Cader MS; De Silva Senapathi U; Nagy E; Sharif S; Abdul-Careem MF
    BMC Res Notes; 2018 Dec; 11(1):859. PubMed ID: 30514372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of dendritic cells from hepatitis B virus transgenic mice-stimulated autologous lymphocytes on hepatitis B virus replication: a study on the impact of specific sensitized effector cells on in vitro virus replication.
    Shen ZY; Zheng WP; Liu T; Yang Y; Song HL
    Viral Immunol; 2015 Mar; 28(2):85-92. PubMed ID: 25343622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone.
    Wakui Y; Inoue J; Ueno Y; Fukushima K; Kondo Y; Kakazu E; Obara N; Kimura O; Shimosegawa T
    Biochem Biophys Res Commun; 2010 May; 396(2):508-14. PubMed ID: 20430009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 To Repress IFN/JAK/STAT Signaling.
    Chen J; Xu W; Chen Y; Xie X; Zhang Y; Ma C; Yang Q; Han Y; Zhu C; Xiong Y; Wu K; Liu F; Liu Y; Wu J
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-35 stimulates hepatitis B virus transcription and replication by targeting transcription factor HNF4α.
    Tao NN; Gong R; Chen X; He L; Ren F; Yu HB; Chen J; Ren JH
    J Gen Virol; 2018 May; 99(5):645-654. PubMed ID: 29561254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factors.
    Chen SH; Wu HL; Kao JH; Hwang LH
    PLoS One; 2012; 7(5):e36984. PubMed ID: 22615863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of interleukin-1β in patients with chronic hepatitis B treated with pegylated-interferon-alpha combined with tenofovir disoproxil fumarate and monotherapy.
    Hu X; Luo H; Tan G; Li Y; Qin B
    BMC Gastroenterol; 2023 May; 23(1):163. PubMed ID: 37208599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-23 production of liver inflammatory macrophages to damaged hepatocytes promotes hepatocellular carcinoma development after chronic hepatitis B virus infection.
    Zang M; Li Y; He H; Ding H; Chen K; Du J; Chen T; Wu Z; Liu H; Wang D; Cai J; Qu C
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3759-3770. PubMed ID: 30292634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes/macrophages by interfering with JNK activation.
    Wang S; Chen Z; Hu C; Qian F; Cheng Y; Wu M; Shi B; Chen J; Hu Y; Yuan Z
    J Immunol; 2013 May; 190(10):5142-51. PubMed ID: 23585678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivo.
    Cheng ST; Tang H; Ren JH; Chen X; Huang AL; Chen J
    PLoS One; 2017; 12(6):e0179605. PubMed ID: 28614380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages.
    Cheng X; Xia Y; Serti E; Block PD; Chung M; Chayama K; Rehermann B; Liang TJ
    Hepatology; 2017 Dec; 66(6):1779-1793. PubMed ID: 28665004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.